PathMaker secures funding from US DoD for neuromodulation ALS trial
The $2.16m grant will fund PathMaker’s expanded pilot CALM study evaluating MyoRegulator in patients with ALS.The post PathMaker secures funding from US DoD for neuromodulation ALS trial appeared first on Medical Device Network.
The $2.16m grant will fund PathMaker’s expanded pilot CALM study evaluating MyoRegulator in patients with ALS.
The post PathMaker secures funding from US DoD for neuromodulation ALS trial appeared first on Medical Device Network.
What's Your Reaction?
![[Computex] The new be quiet cooling!](https://technetspot.com/uploads/images/202406/image_100x75_6664d1b926e0f.jpg)
